Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios

BACKGROUND: Prostate cancer screening incurs a high risk of overdiagnosis and overtreatment. An organized and age‐targeted screening strategy may reduce the associated harms while retaining or enhancing the benefits. METHODS: Using a micro‐simulation analysis (MISCAN) model, we assessed the harms, b...

Descripción completa

Detalles Bibliográficos
Autores principales: Getaneh, Abraham M., Heijnsdijk, Eveline A. M., Roobol, Monique J., de Koning, Harry J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571827/
https://www.ncbi.nlm.nih.gov/pubmed/32813910
http://dx.doi.org/10.1002/cam4.3395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571827/
https://www.ncbi.nlm.nih.gov/pubmed/32813910
http://dx.doi.org/10.1002/cam4.3395

Ejemplares similares